IGF-1 Receptor Signaling in Mammary Gland Development

乳腺发育中的 IGF-1 受体信号传导

基本信息

  • 批准号:
    6709357
  • 负责人:
  • 金额:
    $ 26.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-01-24 至 2007-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The cells of the terminal end bud (TEB) are the most proliferative and invasive cells found during postnatal development in mammals. These cells, through their enormous proliferative capacity, drive the development of the entire mammary ductal system, serve as a source of mammary progenitor cells, and are the single most important target for carcinogens within the mammary gland. The ability of endocrine-, paracrine- and extracellular matrix-derived signals to harness this enormous regenerative potential and direct it into a highly ordered developmental pattern makes the TEB both an important and very fascinating system with which to study the endocrine regulation of intracellular signaling. Our analysis of grafted mammary tissue from a knockout mouse model has demonstrated that a targeted inactivating mutation of the gene for the IGF-I receptor (lgf1r) dramatically reduces mammary ductal development and decreases TEB cell proliferation(1). This proliferative defect, however, is partial restored by early pregnancy. In breast cancer cell models the IGF-I receptor as well as a handful of other hormone receptors signal through insulin receptor substrate (IRS) proteins, and two serine threonine kinases, ERK and Akt. The overall hypothesis addressed in this proposal is that IGF-I receptor stimulates TEB cell proliferation through insulin responsive substrate (IRS)-dependent activation of ERK and Akt during virgin ductal development and that pregnancy or the ovarian steroid hormones estradiol (E2) and progesterone (P) increase the sensitivity of IRS-dependent signaling pathways to insulin receptor-dependent activation in Igf1r-/- TEB. Through the use confocal microscopy with recently developed antibodies to detect cell signaling in-situ, we will learn how signaling pathways are regulated in TEBs and what the significance of these pathways is to processes important to both normal mammary gland function and breast cancer. The specific aims are; 1) determine if estrus cycle, ovarectomy, early pregnancy, or exogenous E2+P alters IGF-I-, or insulin-induced phosphorylation of IRS-1, -2, ERK and Akt in mammary glands of normal mice, 2) determine if IGF-IR or IR dependent activation of ERK, and Akt is attenuated in the TEB of lgf1r -/- grafts and if early pregnancy or exogenous E2+P can restore this activation, and 3) determine if overexpression of IRS-1 or IRS-2 within the mammary epithelium restores development of Igf1r-/- mammary epithelium and enhances insulin-dependent posphorylation of ERK and Akt.
描述(由申请人提供): 终芽(TEB)细胞是哺乳动物出生后发育过程中发现的最具增殖性和侵袭性的细胞。这些细胞通过其巨大的增殖能力,驱动整个乳腺导管系统的发育,作为乳腺祖细胞的来源,并且是乳腺内致癌物的最重要的单一目标。内分泌、旁分泌和细胞外基质衍生信号能够利用这种巨大的再生潜力并将其引导至高度有序的发育模式,这使得 TEB 成为研究细胞内信号传导的内分泌调节的重要且非常迷人的系统。我们对基因敲除小鼠模型移植乳腺组织的分析表明,IGF-I 受体 (lgf1r) 基因的靶向失活突变可显着降低乳腺导管发育并降低 TEB 细胞增殖 (1)。然而,这种增殖缺陷可以通过早期妊娠部分恢复。在乳腺癌细胞模型中,IGF-I 受体以及一些其他激素受体通过胰岛素受体底物 (IRS) 蛋白和两种丝氨酸苏氨酸激酶 ERK 和 Akt 发出信号。该提案提出的总体假设是,在处女导管发育过程中,IGF-I 受体通过胰岛素反应底物 (IRS) 依赖性 ERK 和 Akt 激活来刺激 TEB 细胞增殖,并且妊娠或卵巢类固醇激素雌二醇 (E2) 和孕酮 (P) 会增加 IRS 依赖性信号通路对胰岛素受体依赖性激活的敏感性。 Igf1r-/- TEB。通过使用共聚焦显微镜和最近开发的抗体来原位检测细胞信号传导,我们将了解 TEB 中如何调节信号传导通路,以及这些通路对正常乳腺功能和乳腺癌的重要过程有何意义。具体目标是; 1) 确定发情周期、卵巢切除、早期妊娠或外源性 E2+P 是否会改变正常小鼠乳腺中的 IGF-I- 或胰岛素诱导的 IRS-1、-2、ERK 和 Akt 磷酸化,2) 确定 IGF-IR 或 IR 依赖性 ERK 和 Akt 激活是否在 lgf1r -/- 移植物的 TEB 中减弱,如果 妊娠早期或外源性 E2+P 可以恢复这种激活,3) 确定乳腺上皮内 IRS-1 或 IRS-2 的过度表达是否会恢复 Igf1r-/- 乳腺上皮的发育并增强 ERK 和 Akt 的胰岛素依赖性磷酸化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DARRYL L HADSELL其他文献

DARRYL L HADSELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DARRYL L HADSELL', 18)}}的其他基金

The Microbiome in Mammary Development, and Lacatation
乳腺发育和哺乳中的微生物组
  • 批准号:
    9430549
  • 财政年份:
    2018
  • 资助金额:
    $ 26.34万
  • 项目类别:
Maternal obesity and mammary cell mitochondrial function during lactation
哺乳期母亲肥胖与乳腺细胞线粒体功能
  • 批准号:
    8037759
  • 财政年份:
    2010
  • 资助金额:
    $ 26.34万
  • 项目类别:
Maternal obesity and mammary cell mitochondrial function during lactation
哺乳期母亲肥胖与乳腺细胞线粒体功能
  • 批准号:
    7787807
  • 财政年份:
    2010
  • 资助金额:
    $ 26.34万
  • 项目类别:
QTL and QTL Genes Underlying Lactation Performance
QTL 和影响泌乳性能的 QTL 基因
  • 批准号:
    7805534
  • 财政年份:
    2009
  • 资助金额:
    $ 26.34万
  • 项目类别:
QTL and QTL Genes Underlying Lactation Performance
QTL 和影响泌乳性能的 QTL 基因
  • 批准号:
    7660129
  • 财政年份:
    2009
  • 资助金额:
    $ 26.34万
  • 项目类别:
INSULIN AND IGF-1 RECEPTORS IN MAMMARY DEVELOPMENT
乳腺发育中的胰岛素和 IGF-1 受体
  • 批准号:
    6342493
  • 财政年份:
    1997
  • 资助金额:
    $ 26.34万
  • 项目类别:
INSULIN AND IGF-1 RECEPTORS IN MAMMARY DEVELOPMENT
乳腺发育中的胰岛素和 IGF-1 受体
  • 批准号:
    6138048
  • 财政年份:
    1997
  • 资助金额:
    $ 26.34万
  • 项目类别:
INSULIN AND IGF-1 RECEPTORS IN MAMMARY DEVELOPMENT
乳腺发育中的胰岛素和 IGF-1 受体
  • 批准号:
    2634312
  • 财政年份:
    1997
  • 资助金额:
    $ 26.34万
  • 项目类别:
INSULIN AND IGF-1 RECEPTORS IN MAMMARY DEVELOPMENT
乳腺发育中的胰岛素和 IGF-1 受体
  • 批准号:
    2623985
  • 财政年份:
    1997
  • 资助金额:
    $ 26.34万
  • 项目类别:
INSULIN AND IGF-1 RECEPTORS IN MAMMARY DEVELOPMENT
乳腺发育中的胰岛素和 IGF-1 受体
  • 批准号:
    2856811
  • 财政年份:
    1997
  • 资助金额:
    $ 26.34万
  • 项目类别:

相似海外基金

EFR3: Novel gatekeeper of cell proliferation
EFR3:细胞增殖的新型看门人
  • 批准号:
    DP240102729
  • 财政年份:
    2024
  • 资助金额:
    $ 26.34万
  • 项目类别:
    Discovery Projects
Modulation of cell proliferation by the tumor suppressor protein NRK
肿瘤抑制蛋白 NRK 对细胞增殖的调节
  • 批准号:
    23K08817
  • 财政年份:
    2023
  • 资助金额:
    $ 26.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MR imaging for the cell proliferation using in vivo click chemistry
使用体内点击化学进行细胞增殖的 MR 成像
  • 批准号:
    23K18279
  • 财政年份:
    2023
  • 资助金额:
    $ 26.34万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Project 1: Determine the mechanisms Cyclin D-Cdk4/6 uses to drive cell proliferation
项目 1:确定 Cyclin D-Cdk4/6 驱动细胞增殖的机制
  • 批准号:
    10867552
  • 财政年份:
    2023
  • 资助金额:
    $ 26.34万
  • 项目类别:
Identification of active components of sillkworm serum exhibiting cell proliferation and elucidation of the mechanism
蚕血清中细胞增殖活性成分的鉴定及其机制的阐明
  • 批准号:
    23KJ1691
  • 财政年份:
    2023
  • 资助金额:
    $ 26.34万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The Role of Arginine Transport on Pancreatic Alpha Cell Proliferation and Function
精氨酸转运对胰腺α细胞增殖和功能的作用
  • 批准号:
    10678248
  • 财政年份:
    2023
  • 资助金额:
    $ 26.34万
  • 项目类别:
Regulation of Adherent Cell Proliferation by Matrix Viscoelasticity
基质粘弹性对贴壁细胞增殖的调节
  • 批准号:
    10735701
  • 财政年份:
    2023
  • 资助金额:
    $ 26.34万
  • 项目类别:
mRNA selective translational control required for B cell proliferation
B 细胞增殖所需的 mRNA 选择性翻译控制
  • 批准号:
    2757728
  • 财政年份:
    2022
  • 资助金额:
    $ 26.34万
  • 项目类别:
    Studentship
mechanism of cancer cell proliferation in bone microenvironment of renal cell carcinoma
肾细胞癌骨微环境中癌细胞增殖机制
  • 批准号:
    22K09370
  • 财政年份:
    2022
  • 资助金额:
    $ 26.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Decline of tissue stem cell proliferation and differentiation ability by chronic renal failure and preventive effects by omega-3 polyunsaturated fatty acid
慢性肾功能衰竭引起的组织干细胞增殖和分化能力下降及omega-3多不饱和脂肪酸的预防作用
  • 批准号:
    22K05529
  • 财政年份:
    2022
  • 资助金额:
    $ 26.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了